CClinicalTrials.gg
RecruitingNCT05786313Updated Jul 30, 2026

Study of Individualized, Precise and Standardized Cervical Open-door Surgery for Cervical Spinal Stenosis

An interventional study of Centerpiece titanium plate in Cervical Spinal Stenosis, Cervical Spinal Cord Injury and Individuation, sponsored by Xijing Hospital. Recruiting at 1 site in China. Open to participants aged 28 Years to 85 Years. Per ClinicalTrials.gov, last updated 2026-07-30.

Sponsored by Xijing Hospital · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Mar 2023; still recruiting 3 years 7 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
500
Allocation
Randomized
Ages
28 Years to 85 Years
Sex
All
01

Study summary

To evaluate the safety and effectiveness of individualized, precise and standardized open-door posterior cervical surgery through a single-center, exploratory clinical study, so as to provide a more reliable basis for the treatment of cervical spinal stenosis.

02

Conditions studied

  • Cervical Spinal Stenosis
  • Cervical Spinal Cord Injury
  • Individuation
  • Standardization

Keywords

  • cervical spinal stenosis
  • open angle
03

In context

Lead sponsor

Xijing Hospital is the lead sponsor of 465 studies on the registry; 157 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
28 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • The age of 28-85 years old; Through systematic clinical and imaging examination, patients diagnosed with C3-7 multilevel cervical spondylitis myelopathy or cervical spinal stenosis who need to undergo posterior cervical open-door surgery.
  • No contraindications in preoperative routine tests and examinations.
  • Informed consent of patients.

Exclusion criteria

Exclusion Criteria:

  • Cervical radiculopathy
  • Cervical kyphosis or instability
  • Cervical spondylosis caused by trauma, tumor, tuberculosis and metabolic diseases
  • Revision surgery or combined anterior-posterior surgery is required
  • Serious neurological diseases affect the postoperative effect evaluation
  • Mental illness cannot cooperate with follow-up
  • Contraindications for MRI examination
  • Patients themselves or their families do not agree to participate in the study
  • Other situations that are not suitable for study participation.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Factorial assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
500 participants (estimated)

Study arms

  • Active comparator
    Centerpiece titanium plate

    All surgical operations were performed by the same group of senior spine surgeons. The range of open door decompression involved C3 \~ C7. For convenient operation and more accurate statistics, the right side of the door axis and the left side of the door seam were selected for all operations. Centerpiece titanium plates were used for intraoperative fixation.

    Procedure: Centerpiece titanium plate

  • Experimental
    3D printed arch titanium plate

    Before surgery, according to the imaging results, according to the effective imaging indicators screened in the early stage and the calculated door opening Angle formula, the door opening Angle of the patient's posterior cervical vertebra and the size of the fitted arch titanium plate were designed by mimics 10.0 software, and the titanium plate was printed using 3D printing technology. During the operation, the developed laminae opener was used to accurately control the door opening Angle and appropriate size titanium plate was installed for internal fixation. The standardized laminae door opening guide was used to complete the preparation of the door shaft side and door opening side of the lamina

    Procedure: Centerpiece titanium plate

Interventions

  • ProcedureCenterpiece titanium plate

    All indexes were collected from the patients with Centerpiece titanium plate for internal fixation.

06

What researchers measure

Primary outcomes

  1. JOA score change

    Japanese Orthopedic Association (JOA) score is used to assess the function of spinal cord which is in the form of questionnaires. Postoperative improvement rate = ((postoperative score - preoperative score)/ (17- preoperative score)) X100%. Improvement rate can also correspond to the commonly used efficacy criteria: cure when the improvement rate is 100%, effective when the improvement rate is greater than 60%, effective when 25-60%, and ineffective when less than 25%.

    Time frame: pre-operation,3 months after surgery, 6 months after surgery, 1 year after surgery

  2. NDI score change

    Neck Disability Index (NDI) score is used to assess the disorder of spinal cord which is in the form of questionnaires. Postoperative improvement rate = (total score)/ (numbers of program X5) X100%. Improvement rate can also correspond to the commonly used efficacy criteria: the improvement rate when 60%-80% means extremely severe dysfunction, when 40%-60% means severe dysfunction, when 20-40% means moderate dysfunction, and when less than 20% means mild dysfunction.

    Time frame: pre-operation,3 months after surgery, 6 months after surgery, 1 year after surgery

  3. VAS score

    A Visual Analogue Scale (VAS) is used to measure the amount of pain that a patient feels ranges across a continuum from none to an extreme amount of pain. Using a ruler, the score is determined by measuring the distance (mm) on the 10cm line between the "no pain" anchor and the patient's mark, providing a range of scores from 0-100. A higher score indicates greater pain intensity.

    Time frame: pre-operation,3 months after surgery, 6 months after surgery, 1 year after surgery

Secondary outcomes

  1. Maximum spinal cord compression change

    This index was measured by MRI, which was the ratio of the diameter of the cervical pulp at the most compressed segment to the mean diameter of the cervical pulp at the upper and lower segments without compression.

    Time frame: pre-operation,3 months after surgery, 6 months after surgery, 1 year after surgery

  2. Compression ratio change

    This index was measured by MRI, which means the minimum sagittal diameter of the cervical pulp in the most compressed segment divided by maximum transverse diameter.

    Time frame: pre-operation,3 months after surgery, 6 months after surgery, 1 year after surgery

  3. Transverse area change

    This index was measured by MRI, which means the cross-sectional area of the cervical pulp at the highest level of compression.

    Time frame: pre-operation,3 months after surgery, 6 months after surgery, 1 year after surgery

07

Study locations

1 of 1 sites recruiting
  • Qi Wei
    Xi'an, Shannxi Province 710034, China
    Recruiting
08

References and documents

Publications

  • Schmeiser G, Bergmann JI, Papavero L, Kothe R. Surgical Treatment of Multilevel Degenerative Cervical Myelopathy: Open-Door Laminoplasty and Fixation via Unilateral Approach. A Feasibility Study. J Neurol Surg A Cent Eur Neurosurg. 2022 Sep;83(5):494-501. doi: 10.1055/s-0041-1739224. Epub 2021 Dec 15. PubMed 34911089 ↗
  • Yeh KT, Lee RP, Chen IH, Yu TC, Liu KL, Peng CH, Wang JH, Wu WT. Laminoplasty instead of laminectomy as a decompression method in posterior instrumented fusion for degenerative cervical kyphosis with stenosis. J Orthop Surg Res. 2015 Sep 4;10:138. doi: 10.1186/s13018-015-0280-y. PubMed 26338009 ↗
  • Chen H, Liu H, Zou L, Li T, Gong Q, Song Y, Zeng J, Liu L, Kong Q. Effect of Mini-plate Fixation on Hinge Fracture and Bony Fusion in Unilateral Open-door Cervical Expansive Laminoplasty. Clin Spine Surg. 2016 Jul;29(6):E288-95. doi: 10.1097/BSD.0000000000000131. PubMed 25023712 ↗
  • Yuan W, Zhu Y, Liu X, Zhu H, Zhou X, Zhou R, Cui C, Li J. Postoperative three-dimensional cervical range of motion and neurological outcomes in patients with cervical ossification of the posterior longitudinal ligament: Cervical laminoplasty versus laminectomy with fusion. Clin Neurol Neurosurg. 2015 Jul;134:17-23. doi: 10.1016/j.clineuro.2015.04.004. Epub 2015 Apr 17. PubMed 25929463 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 30, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05786313
Lead sponsor
Xijing Hospital
Responsible party
Sponsor
First posted
Mar 27, 2023
Start date
Mar 1, 2023
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Jul 30, 2026

Study contacts

Wei Qi
Contact
14556263@qq.com
+862984771012

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion